Topical Formula Reduces Retinoid Irritation in Pilot Study
A topical formulation combining tretinoin with a skin-barrier-supporting ingredient reduces redness, dryness, and irritation associated with retinoid use.
A topical formulation combining tretinoin with a skin-barrier-supporting ingredient reduces redness, dryness, and irritation associated with retinoid use.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.